NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

464 hedge funds and large institutions have $10B invested in Neurocrine Biosciences in 2022 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 162 increasing their positions, 159 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
464
Holders Change
+29
Holders Change %
+6.67%
% of All Funds
8.02%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.21%
New
80
Increased
162
Reduced
159
Closed
44
Calls
$35.1M
Puts
$27.4M
Net Calls
+$7.7M
Net Calls Change
-$66.6M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$1.05B
2
Los Angeles Capital Management
2
Los Angeles Capital Management
California
$84.1M
3
Amundi
3
Amundi
France
$88.7M
4
Invesco
4
Invesco
Georgia
$96.2M
5
Allspring Global Investments
5
Allspring Global Investments
North Carolina
$57.3M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$155M
2
Holocene Advisors
2
Holocene Advisors
New York
$0
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$252M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
DM
5
Deerfield Management
New York
$161M
Name Holding Trade Value Shares
Change 		Shares
Change %
PMFA
501
Plante Moran Financial Advisors
Michigan
– -$2K -18 Closed
Jones Financial Companies
502
Jones Financial Companies
Missouri
– -$1K -13 Closed
SFG
503
Steward Financial Group
Texas
– -$1K -11 Closed
17 18 19 20
21